Gene Products, env

DBCAT002890Pharmacologic class

Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesized as protein precursors (POLYPROTEINS) and later cleaved into the final viral envelope glycoproteins by a viral protease. A DrugBank category of 2 drugs. 1 of them is approved.

Also known as: Antigens, env · env Antigens · env Gene Products · env Glycoproteins · env Polyprotein
Drugs: Enfuvirtide
Tifuvirtide

What you can answer from here — as of November 01, 2016

2DrugsEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

9Marketed productsAcross the regions we cover, with dosage forms and routes

2Routes of administrationHow the drugs in this class are given

Which targets do Gene Products, env share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account